{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:49:41Z","timestamp":1790912981435,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.ijantimicag.2007.10.017","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T12:36:19Z","timestamp":1199709379000},"page":"142-146","source":"Crossref","is-referenced-by-count":53,"title":["Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles"],"prefix":"10.1016","volume":"31","author":[{"given":"Zahoor","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhna","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.K.","family":"Khuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2007.10.017_bib1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0006-2952(01)00571-8","article-title":"Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis","volume":"61","author":"Guardiola-Diaz","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.femsle.2005.07.022","article-title":"In vitro and ex vivo antimycobacterial potential of azole drugs against M. tuberculosis H37RV","volume":"251","author":"Ahmad","year":"2005","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1574-6968.2006.00350.x","article-title":"Azole antifungals as novel chemotherapeutic agents against murine tuberculosis","volume":"261","author":"Ahmad","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijantimicag.2006.07.028","article-title":"Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis","volume":"28","author":"Ahmad","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/AAC.00414-06","article-title":"Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy","volume":"51","author":"Shandil","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1164\/rccm.200407-885OC","article-title":"Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis","volume":"170","author":"Nuermberger","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib7","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/424849","article-title":"Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling","volume":"190","author":"Gumbo","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijpharm.2005.05.027","article-title":"Nano-encapsulation of azole antifungals: potential applications to improve oral drug bioavailability","volume":"301","author":"Pandey","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10717540500398076","article-title":"Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs","volume":"13","author":"Pandey","year":"2006","journal-title":"Drug Deliv"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib10","first-page":"81","article-title":"Evaluation of antitubercular drug loaded alginate nanoparticles against experimental tuberculosis","volume":"1","author":"Zahoor","year":"2006","journal-title":"J Nanoscience"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib11","first-page":"420","article-title":"Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two doses","volume":"27","author":"Zahoor","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tube.2003.07.001","article-title":"Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis","volume":"83","author":"Pandey","year":"2003","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib13","first-page":"575","article-title":"Impact of iron loading on the activity of isoniazid or ethambutol in the treatment of murine tuberculosis","volume":"7","author":"Lounis","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1099\/mic.0.27938-0","article-title":"Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole","volume":"151","author":"Burguiere","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2007.10.017_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1574-6968.2006.00224.x","article-title":"The potential of azole antifungals against latent\/persistent tuberculosis","volume":"258","author":"Ahmad","year":"2006","journal-title":"FEMS Microbiol Lett"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907005419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907005419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T22:24:09Z","timestamp":1546381449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907005419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0924857907005419"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.10.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}